Cover Image

Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples

Abstract Purpose The clinical significance of negative toxin enzyme immunoassays (EIA) for Clostridioides difficile infections (CDIs) is unclear. Our study aimed to investigate the significance of toxin EIA-negative in the diagnosis and prognosis of CDI. Methods All stool specimens submitted for C....

Full description

Saved in:

Bibliographic Details
Main Authors:	Dae Hyeon Cho (Author), Si-Ho Kim (Author), Cheon Hoo Jeon (Author), Hyoung Tae Kim (Author), Kyoung-Jin Park (Author), Junyoung Kim (Author), Jiyeong Kwak (Author), Byung Soo Kwan (Author), Sungmin Kong (Author), Jung Won Lee (Author), Kwang Min Kim (Author), Yu Mi Wi (Author)
Format:	Book
Published:	BMC, 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prevalence of Non-Toxigenic <i>Clostridioides difficile</i> in Diarrhoea Patients and Their Clinical Characteristics
by: Cheon-Hoo Jeon, et al.
Published: (2023)

<i>Clostridioides difficile</i> Toxin B PCR Cycle Threshold as a Predictor of Toxin Testing in Stool Specimens from Hospitalized Adults
by: Sean Lee, et al.
Published: (2022)

Quantitative PCR for early detection of human cytomegalovirus end-organ disease in immunocompetent host: A retrospective single-center study
by: Cheon-Hoo Jun, et al.
Published: (2024)

Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol
by: Sebastian Heber, et al.
Published: (2022)

Iron Effects on <i>Clostridioides difficile</i> Toxin Production and Antimicrobial Susceptibilities
by: Jason Yamaki, et al.
Published: (2022)

Proinflammatory Cytokines: Possible Accomplices for the Systemic Effects of Clostridioides difficile Toxin B
by: Fettucciari K, et al.
Published: (2021)

Clostridioides difficile Infection
Published: (2022)

Clinician Interpretation and Management of Discordant PCR+/Toxin- Clostridioides difficile Testing Results Post-COVID
by: Noah Boton, et al.
Published: (2024)

Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target <i>Clostridioides difficile</i>
by: Dahyun Kim, et al.
Published: (2022)

Human α-Defensin-5 Efficiently Neutralizes Clostridioides difficile Toxins TcdA, TcdB, and CDT
by: Michael Korbmacher, et al.
Published: (2020)

High Serum Levels of Toxin A Correlate with Disease Severity in Patients with <i>Clostridioides difficile</i> Infection
by: Guido Granata, et al.
Published: (2021)

Diagnostic Methods of <i>Clostridioides difficile</i> Infection and <i>Clostridioides difficile</i> Ribotypes in Studied Sample
by: Elena Novakova, et al.
Published: (2021)

Clostridioides difficile: A diagnostic intervention
by: Majd Alsoubani, et al.
Published: (2022)

Prevalence, Antimicrobial Resistance and Toxin-Encoding Genes of <i>Clostridioides difficile</i> from Environmental Sources Contaminated by Feces
by: Khald Blau, et al.
Published: (2023)

Ineffectiveness of colistin monotherapy in treating carbapenem-resistant Acinetobacter baumannii Pneumonia: A retrospective single-center cohort study
by: Cheon-Hoo Jeon, et al.
Published: (2024)

Expansion of a versatile pathogen: Clostridioides difficile
by: Tereena Lucas, et al.
Published: (2024)

Fidaxomicin Use in the Pediatric Population with Clostridioides difficile
by: Oliver MB, et al.
Published: (2022)

Pleiotropic Clostridioides difficile Cyclophilin PpiB Controls Cysteine-Tolerance, Toxin Production, the Central Metabolism and Multiple Stress Responses
by: Can Murat Ünal, et al.
Published: (2019)

Genetic Relatedness of 5-Year Isolates of <i>Clostridioides difficile</i> Polymerase Chain Reaction Ribotype 017 Strains in a Hospital
by: Jieun Kim, et al.
Published: (2021)

Risk Factors for Recurrence of Clostridioides difficile in Hospitalized Patients
by: Diaa Alrahmany, et al.
Published: (2021)

Outbreak of Clostridioides difficile infection in Silesian district hospital
by: Klaudia T. Szarek, et al.
Published: (2023)

Introduction to the Special Issue on <i>Clostridioides difficile</i>
by: Guido Granata, et al.
Published: (2021)

Opportunities for Nanomedicine in <i>Clostridioides difficile</i> Infection
by: Pei-Wen Wang, et al.
Published: (2021)

Clostridioides Difficile Enteritis: Case Report and Literature Review
by: Artsiom Klimko, et al.
Published: (2022)

Current Diagnostic and Treatment Approach of Clostridioides difficile Infection
by: Bella Yunita, et al.
Published: (2023)

Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
by: Chang Mo Moon, et al.
Published: (2021)

Impact of Clostridioides difficile Reporting on Antimicrobial Therapy Days Directed at Treatment of C. difficile Infections
by: Ardath Plauche, et al.
Published: (2024)

Prevalence and detection of Tropheryma whipplei in the stools of Korean patients with diarrhea using real-time PCRs
by: Sumi Yoon, et al.
Published: (2022)

Meta-analysis of predictors of healthcare-associated Clostridioides difficile infection
by: Jesse Fajnzylber, et al.
Published: (2024)

Clostridioides Difficile: A Concise Review of Best Practices and Updates
by: Abdelrahman Yakout, et al.
Published: (2024)

Clostridioides difficile infections in Saudi Arabia: Where are we standing?
by: Najla A. Obaid, et al.
Published: (2020)

Clostridioides difficile infection in intensive care units in nursing practice
by: Izabela Fajfer-Gryz, et al.
Published: (2020)

Clostridioides difficile infection: a comprehensive review for primary providers
by: Cortés Pedro, et al.
Published: (2021)

Clostridioides difficile infection leading to fulminant colitis with toxic megacolon
by: Fareed Rajack, et al.
Published: (2023)

Hospital-Onset Clostridioides difficile infection in chronic kidney disease patients
by: Anita Shallal, et al.
Published: (2024)

Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
by: Andrew T. Dysangco, et al.
Published: (2022)

Clostridioides difficile infection in trials of short versus long duration of antimicrobials
by: Dimitri M. Drekonja, et al.
Published: (2024)

Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection
by: Zeitler Kristen, et al.
Published: (2023)

Improving Culture yield rates for clostridioides difficile by using CHROMagarTM
by: T. Yi-Chun, et al.
Published: (2020)

The Economic Burden of Clostridioides difficile in Denmark: A Retrospective Cohort Study
by: Uffe Christian Braae, et al.
Published: (2020)